Request for Covid-19 Impact Assessment of this Report
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
The global Postmenopausal Vaginal Atrophy Treatment market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Creams
Tablets
Patches
Rings
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Allergan
Pfizer
Shionogi
Novo Nordisk
Teva Pharmaceutical
Bayer.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Topical Estrogen
Systemic Estrogen
Non-hormonal Therapy
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Creams
1.2.1.2 Tablets
1.2.1.3 Patches
1.2.1.4 Rings
1.2.2 by Application
1.2.2.1 Topical Estrogen
1.2.2.2 Systemic Estrogen
1.2.2.3 Non-hormonal Therapy
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Creams Market, 2013-2018
4.1.2 Tablets Market, 2013-2018
4.1.3 Patches Market, 2013-2018
4.1.4 Rings Market, 2013-2018
4.2 Market Forecast
4.2.1 Creams Market Forecast, 2019-2024
4.2.2 Tablets Market Forecast, 2019-2024
4.2.3 Patches Market Forecast, 2019-2024
4.2.4 Rings Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Topical Estrogen Market, 2013-2018
5.1.2 Systemic Estrogen Market, 2013-2018
5.1.3 Non-hormonal Therapy Market, 2013-2018
5.2 Market Forecast
5.2.1 Topical Estrogen Market Forecast, 2019-2024
5.2.2 Systemic Estrogen Market Forecast, 2019-2024
5.2.3 Non-hormonal Therapy Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Allergan
8.2 Pfizer
8.3 Shionogi
8.4 Novo Nordisk
8.5 Teva Pharmaceutical
8.6 Bayer.
9 Conclusion
Table Products Segment of Postmenopausal Vaginal Atrophy Treatment
Table Creams Overview
Table Tablets Overview
Table Patches Overview
Table Rings Overview
Table Global Postmenopausal Vaginal Atrophy Treatment Market by Type, 2011-2022 (USD Million)
Table Application Segment of Postmenopausal Vaginal Atrophy Treatment
Table Topical Estrogen Overview
Table Systemic Estrogen Overview
Table Non-hormonal Therapy Overview
Table Global Postmenopausal Vaginal Atrophy Treatment Market by Application, 2011-2022 (USD Million)
Table Global Postmenopausal Vaginal Atrophy Treatment Market by Region, 2011-2022 (USD Million)
Table Cost of Postmenopausal Vaginal Atrophy Treatment
Table Market Dynamics
Table Policy of Postmenopausal Vaginal Atrophy Treatment
Table GDP of Major Countries
Table Creams CAGR by Revenue and Volume, 2012-2018
Table Tablets CAGR by Revenue and Volume, 2012-2018
Table Patches CAGR by Revenue and Volume, 2012-2018
Table Rings CAGR by Revenue and Volume, 2012-2018
Table Creams CAGR by Revenue and Volume, 2012-2024
Table Tablets CAGR by Revenue and Volume, 2012-2024
Table Patches CAGR by Revenue and Volume, 2012-2024
Table Rings CAGR by Revenue and Volume, 2012-2024
Table Topical Estrogen CAGR by Revenue and Volume, 2012-2018
Table Systemic Estrogen CAGR by Revenue and Volume, 2012-2018
Table Non-hormonal Therapy CAGR by Revenue and Volume, 2012-2018
Table Global Postmenopausal Vaginal Atrophy Treatment Market by Vendors, 2012-2018 (USD Million)
Table Global Postmenopausal Vaginal Atrophy Treatment Market by Vendors, 2012-2018 (in Volume)
Table Global Postmenopausal Vaginal Atrophy Treatment Market Share by Vendors, 2012-2018 (USD Million)
Table Global Postmenopausal Vaginal Atrophy Treatment Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Allergan Profile List
Table Microecological Modulator Operating Data of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shionogi Profile List
Table Microecological Modulator Operating Data of Shionogi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Profile List
Table Microecological Modulator Operating Data of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer. Profile List
Table Microecological Modulator Operating Data of Bayer. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...